Responses
Clinical and epidemiological research
Extended report
Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study
Compose a Response to This Article
Other responses
No responses have been published for this article.